A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

This publication has 53 references indexed in Scilit:

• Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials: An Analysis of the Food and Drug Administration Database
  American Journal of Psychiatry, 2001
• Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
  Science, 2001
• Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men
  European Journal of Clinical Nutrition, 2001
• An ELISA method for type IV cPLA2 in RBC: A potential marker for schizophrenia
  Schizophrenia Research, 2000
• ω3 Fatty Acids and Cardiovascular Disease
  Published by S. Karger AG ,1998
• A Self-Rating Scale for Measuring Neuroleptic Side-Effects
  The British Journal of Psychiatry, 1995
• Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures
  Schizophrenia Research, 1994
• Treatment of Diabetic Neuropathy With γ-Linolenic Acid
  Diabetes Care, 1993
• A New Depression Scale Designed to be Sensitive to Change
  The British Journal of Psychiatry, 1979
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
  Acta Psychiatrica Scandinavica, 1970